We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Exploring the Science behind Bifidobacterium breve M-16V in Infant Health.
- Authors
Wong, Chyn Boon; Iwabuchi, Noriyuki; Xiao, Jin-zhong
- Abstract
Probiotics intervention has been proposed as a feasible preventative approach against adverse health-related complications in infants. Nevertheless, the umbrella concept of probiotics has led to a massive application of probiotics in a range of products for promoting infant health, for which the strain-specificity, safety and efficacy findings associated with a specific probiotics strain are not clearly defined. Bifidobacterium breve M-16V is a commonly used probiotic strain in infants. M-16V has been demonstrated to offer potential in protecting infants from developing the devastating necrotising enterocolitis (NEC) and allergic diseases. This review comprehends the potential beneficial effects of M-16V on infant health particularly in the prevention and treatment of premature birth complications and immune-mediated disorders in infants. Mechanistic studies supporting the use of M-16V implicated that M-16V is capable of promoting early gut microbial colonisation and may be involved in the regulation of immune balance and inflammatory response to protect high-risk infants from NEC and allergies. Summarised information on M-16V has provided conceptual proof of the use of M-16V as a potential probiotics candidate aimed at promoting infant health, particularly in the vulnerable preterm population.
- Subjects
AUTOIMMUNE disease prevention; PREMATURE infants; THERAPEUTIC use of probiotics; ALLERGIES; BIFIDOBACTERIUM; HEALTH promotion; IMMUNITY; PREVENTIVE health services; GUT microbiome; PROBIOTICS; ENTEROCOLITIS; CHILDREN; PREVENTION
- Publication
Nutrients, 2019, Vol 11, Issue 8, p1724
- ISSN
2072-6643
- Publication type
Article
- DOI
10.3390/nu11081724